Skip to main content

Table 3 Details of surgical complications and the number of cases between both groups

From: Study on the efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy regimen for III–IVA esophageal squamous cell carcinoma post-surgery

Complications and Clavien-Dindo classification

Observation group

Control group

P-value

Anastomotic fistula

3

6

1.0

Grade II

1

3

 

Grade III

2

3

 

Postoperative lung infection rate

7

7

1.0

Grade II

7

7

 

Grade III

0

0